BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 9102884)

  • 1. [Our protocol in the treatment of peritonitis in patients on continuous ambulatory peritoneal dialysis].
    Kostić S; Ljuvenović S; Velicković R; Stefanović V; Raicević R; Cukuranović R; Veljković S; Djordjević V; Malobabić Z
    Srp Arh Celok Lek; 1996; 124 Suppl 1():149-51. PubMed ID: 9102884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of meropenem plus tobramycin followed by meropenem plus vancomycin for treating peritonitis in patients on continuous ambulatory peritoneal dialysis.
    Kobayashi K; Nakamoto H; Okada S; Hoshitani K; Uchida K; Arima H; Shoda J; Takane Y; Ikeda N; Sugahara S; Okada H; Suzuki H
    Adv Perit Dial; 2006; 22():65-8. PubMed ID: 16983942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Peritonitis in continuous ambulatory peritoneal dialysis. An evaluation of the empiric initial antibiotic treatment].
    Hagelskjaer LH; Møller JK
    Ugeskr Laeger; 1996 Apr; 158(18):2532-7. PubMed ID: 8686006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of peritoneal dialysis-associated peritonitis with continuous versus intermittent vancomycin/teicoplanin and ceftazidime in children: preliminary results of a prospective randomized trial. Members of APN Arbeitsgemeinschaft Paidiatrische Nephrologie.
    Klaus G; Schaefer F; Müller-Wiefel D; Mehls O
    Adv Perit Dial; 1995; 11():296-301. PubMed ID: 8534728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment and prevention of relapses of CAPD Pseudomonas peritonitis.
    Pasadakis P; Thodis E; Eftimimiadou A; Panagoutsos S; Papazoglou D; Kaliengidou M; Kartali S; Vargemezis V
    Adv Perit Dial; 1993; 9():206-10. PubMed ID: 8105925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cefazolin and netilmycin versus vancomycin and ceftazidime in the treatment of CAPD peritonitis.
    Gucek A; Bren AF; Hergouth V; Lindic J
    Adv Perit Dial; 1997; 13():218-20. PubMed ID: 9360685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The treatment of staphylococcus peritonitis in patients on continuous ambulatory peritoneal dialysis.
    Drinovec J; Bren A; Gucek A; Lindic J; Kandus A; Ponikvar R
    Chemioterapia; 1988 Feb; 7(1):46-8. PubMed ID: 3378276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of vancomycin plus tobramycin as antiperitonitis regimen for patients on CAPD.
    Vargemezis V; Thodis E; Pasadakis P; Martinis G; Kousta E
    Adv Perit Dial; 1990; 6():123-5. PubMed ID: 1982788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pseudomonas peritonitis in CAPD patients: characteristics and outcome of treatment.
    Chan MK; Chan PC; Cheng IP; Chan CY; Ng WS
    Nephrol Dial Transplant; 1989; 4(9):814-7. PubMed ID: 2516614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitric oxide is a marker of peritonitis in patients on continuous ambulatory peritoneal dialysis.
    Choi KC; Jeong TK; Lee SC; Kim SW; Kim NH; Lee KY
    Adv Perit Dial; 1998; 14():173-9. PubMed ID: 10649719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initial intraperitoneal therapy for CAPD peritonitis: the Network 9 Peritonitis Study.
    Brier ME; Aronoff GR
    Adv Perit Dial; 1994; 10():141-3. PubMed ID: 7999812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pseudomonas peritonitis and continuous ambulatory peritoneal dialysis.
    Krothapalli R; Duffy WB; Lacke C; Payne W; Patel H; Perez V; Senekjian HO
    Arch Intern Med; 1982 Oct; 142(10):1862-3. PubMed ID: 6812523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Peritonitis in continuous ambulatory peritoneal dialysis. Culture of peritoneal dialysate fluid].
    Møller JK; Hagelskjaer LH
    Ugeskr Laeger; 1996 Apr; 158(18):2538-41. PubMed ID: 8686007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of resistant peritonitis in continuous ambulatory peritoneal dialysis with intraperitoneal urokinase: a double-blind clinical trial.
    Innes A; Burden RP; Finch RG; Morgan AG
    Nephrol Dial Transplant; 1994; 9(7):797-9. PubMed ID: 7970121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Transperitoneal resorption of cefotiam in CAPD patients with and without peritonitis].
    Thomae U; Koblinger S
    Med Klin (Munich); 1994 Sep; 89(9):464-8. PubMed ID: 7968880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of CAPD peritonitis with clavulanate potentiated ticarcillin.
    Pasadakis P; Thodis E; Euthimiadou A; Panagoutsos S; Oustoglou E; Kartali S; Vargemezis V
    Adv Perit Dial; 1992; 8():238-41. PubMed ID: 1361796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of the number of peritonitis episodes on peritoneal membrane function].
    Jovanović D; Nesić V; Dimitrijević Z
    Srp Arh Celok Lek; 1999; 127(1-2):28-31. PubMed ID: 10377837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraperitoneal vancomycin and ceftazidime in the treatment of CAPD peritonitis.
    Gray HH; Goulding S; Eykyn SJ
    Clin Nephrol; 1985 Feb; 23(2):81-4. PubMed ID: 3886227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of the epidemiological, clinical and laboratory findings in continuous ambulatory peritoneal dialysis related peritonitis attacks].
    Bulut C; Oztürk R; Yilmaz GR; Parpucu H; Irmak H; Kinikli S; Duranay M; Demiröz AP
    Mikrobiyol Bul; 2008 Apr; 42(2):255-64. PubMed ID: 18697423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extended spectrum beta-lactamase-producing Klebsiella pneumoniae chronic ambulatory peritoneal dialysis peritonitis treated successfully with polymyxin B.
    Parchuri S; Mohan S; Cunha BA
    Heart Lung; 2005; 34(5):360-3. PubMed ID: 16157192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.